Clinical Trials
4 trialsNCT04216329 2026-01-23
Selinexor (KPT-330) in Combination With Temozolomide and Radiation Therapy in Patients With Newly Diagnosed Glioblastoma
National Institutes of Health Clinical Center (CC)
Phase 1 Active not recruiting
NCT02465268 2025-01-14
ATTAC-II
University of Florida
Phase 2 Completed
NCT02366728 2023-06-08
ELEVATE
Duke University
Phase 2 Completed
NCT00693095 2018-01-30
ERaDICATe
Duke University
Phase 1 Completed